Clinical Trial

Phase II Clinical Trial of KJ101in the Treatment of Deep II Degree Burns

Recruiting Phase 2
View on ClinicalTrials.gov →
Record status
This record was last updated June 17, 2025 (before its estimated March 18, 2026 completion). Its status may not reflect the trial's current state.
Summary
This multicentre, randomised, double-blind, dose-finding, active- and placebo-controlled Phase II clinical trial will evaluate the safety, efficacy, pharmacokinetic profile, and immunogenicity of KJ101 for the debridement of deep second-degree burns. The trial will provide supporting evidence for subsequent Phase III trials.
Trial Details
NCT Number NCT07025408
Lead Sponsor Shanghai Bao Pharmaceuticals Co., Ltd.
Conditions Burn, Burn Wounds - Partial Thickness (2nd Degree)
Enrollment 144 participants
Start Date 2025-06-16
Primary Completion 2026-03-18 (estimated)
Study Completion 2026-08-29 (estimated)
Updated on ClinicalTrials.gov 2025-06-17